← Leaderboards
Ba-Bie Teng
University Of Texas Hlth Sci Ctr Houston
$3,407,703
Attributed
$3,407,703
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $558.8K · FY2008–12$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$3,407,703 · 4
By mechanism
R01$2,864,626 · 2
R21$412,500 · 1
S10$130,577 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Fudong Liu$7,013,711
- Barbara E Murray$10,954,897
- Ananth V Annapragada$7,084,879
- Peter A Doris$7,290,742
- Yahuan Lou$5,077,989
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyHyperlipidemiaHypercholesterolemiaPlasmaLengthLeadNovel TherapeuticsArterial Fatty StreakLow-Density LipoproteinsNovel StrategiesIn VivoLaboratoriesLdl Cholesterol LipoproteinsCatalytic DomainCholesterolApolipoproteins BDesignGenesLifeCardiovascular Risk FactorAtherosclerosisOperative Surgical ProceduresCellsProteins
Grant awards (12)
Active Immunity Targeted at PCSK9 for the Treatment of Hypercholesterolemia$225,000
R21 · FY2012 · HL · contact PI
The Novel Approach of RNA Based Therapeutic Technologies$371,250
R01 · FY2011 · HL · contact PI
Active Immunity Targeted at PCSK9 for the Treatment of Hypercholesterolemia$187,500
R21 · FY2011 · HL · contact PI
The Novel Approach of RNA Based Therapeutic Technologies$371,250
R01 · FY2010 · HL · contact PI
The Novel Approach of RNA Based Therapeutic Technologies$371,250
R01 · FY2009 · HL · contact PI
The Novel Approach of RNA Based Therapeutic Technologies$371,250
R01 · FY2008 · HL · contact PI
GENETIC TREATMENT FOR ATHEROSCLEROSIS$334,313
R01 · FY2003 · HL
GENETIC TREATMENT FOR ATHEROSCLEROSIS$335,438
R01 · FY2002 · HL
ABI Prism 7900HT Sequence Detection System$130,577
S10 · FY2002 · RR
GENETIC TREATMENT FOR ATHEROSCLEROSIS$74,500
R01 · FY2002 · HL
GENETIC TREATMENT FOR ATHEROSCLEROSIS$336,375
R01 · FY2001 · HL
GENETIC TREATMENT FOR ATHEROSCLEROSIS$299,000
R01 · FY2000 · HL